We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

23 Dec 2008 07:00

RNS Number : 6493K
Evolvence India Holdings PLC
23 December 2008
 



Evolvence India Holdings Announces its 

Net Asset Value as on 30 September 2008

Douglas, Isle of Man: 23 December 2008 - Evolvence India Holdings plc ("EIH" or "the Company"), (AIM: EIH.L.), an investment company that focuses on private equity in India, today announced its un-audited net asset value of US$ 0.819 per share as at 30 September 2008. 

The Company invests in India through the Evolvence India Fund ("EIF"), the Evolvence India Life Sciences Fund ("EILSF"), the fund managers' network of relationships and other investment opportunities.

Highlights:

The Company's net assets are US$ 53.22 million as at 30 September 2008 

NAV per share is US$ 0.819 as at 30 September 2008 

Key Portfolio Updates:

EIF currently has a portfolio of ten private equity funds and eight co-investments and is currently 80% drawn down.

EILSF has a portfolio of two investments and is currently 32% drawn down.

As at 30 September 2008, EIH had committed US$ 65.1 million, of which US$ 52.0 million had been deployed. EIH has received cash distributions from EIF PCC amounting to US$ 4.3 million to date. EIH has distributed dividends amounting to US$ 2.0 million.

EIH has received the final remittance of US$ 5.6 million from Aqar Holdings on 9 September 2008. This short term loan has been closed with the final remittance. Including all remittances received from Aqar Holdings, EIH has received a sum of US$ 8.5 million, comprising of principal of US$ 7.8 million and interest of US$ 0.7 million.

William Knight, Chairman, Evolvence India Holdings commented, "EIH has delivered a relatively resilient performance in the context of very challenging market conditions. The reduction in NAV per share from US$ 0.903 as at 30 June 2008 to US$ 0.819 is a function of the fall in market values due to the current economic downturn affecting all economies. We anticipate that in the short term valuations are likely to continue to be volatile while the general sentiment remains negative. However, the fundamental attractions of investing in India remain unchanged and the Board is confident that EIH's investment strategy will in time generate excellent returns for shareholders."

 

Enquiries:

EIH 020 7221 3900

William Knight

Cardew Group 020 7930 0777 

Tim Robertson

James Milton

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVPUGWGPUPRGRP
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSFinal Results
27th Jun 20167:00 amRNSReturn of Capital
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.